RJ
Therapeutic Areas
Cytoki Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CK-0045 | Obesity and Type 2 Diabetes | Phase 2 |
Leadership Team at Cytoki Pharma
AL
Anne Louise Kjølbye
Chief Development Officer
MV
Martijn van de Bunt
Chief Scientific Officer
AM
Anuj Madhok
Chief Business Officer
DW
Dorte Waaben
Head of CMC
KS
Karsten Skydsgaard
Head of Non-Clinical Development
CF
Christian Friis
Clinical Project Leader